Magellan - Autologous Stem Cells Brochure

From a regulatory point of view - in Australia - Magellan is only permitted to supply stem cells for treatments that are based upon using a patients ‘own cells’ Treatments based upon using a patient’s ‘own cells’ are called autologous treatments. Autologous stem cell treatments first require that a small amount of ‘fat’ is first sourced/removed from the patient in order to ‘obtain cells’. This fat/tissue is normally obtained via a small lipo-suction procedure. Magellan stem cell treatments are based upon Magellan firstly isolating the stem cells from the ‘fat/tissue, and then culturing (expanding) the stem cells such as to be able to supply large therapeutic doses of expanded stem cells to clinicians.